What is the mechanism of action of rituximab?
What is the mechanism of action of rituximab?
Rituximab targets CD20, a transmembrane protein present on virtually all B cells from the stage at which they become committed to B-cell development until it is downregulated when they differentiate into antibody-secreting plasma cells (Reff et al., 1994).
What is rituximab and how does it work?
Rituximab is a monoclonal antibody. It targets a protein called CD20 on the surface of the leukaemia and lymphoma cells. Rituximab sticks to all the CD20 proteins it finds. Then the cells of the immune system pick out the marked cells and kill them.
What are the three different ways rituximab results in cell lysis?
The effect of Rituximab results from its regulatory effect on the cell cycle, including apoptosis stimulation, complement-dependent B-cell lysis, and antibody-dependent cell-mediated cytotoxicity [134].
How does rituximab cause apoptosis?
The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism. Blood.
How long is your immune system compromised after rituximab?
Immune reconstitution starts usually after six months with recovery to normal between nine to twelve months. Extended rituximab treatment results in a prolonged recovery of B-cells without an increase of clinically relevant infections.
How does rituximab work?
Rituximab works by lowering the activity of these B-cells, to reduce inflammation, pain and swelling. If rituximab works for you, you’ll probably start to feel better after around six weeks.
Is rituximab a monoclonal antibody?
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab was approved for medical use in 1997.
What is Rituximab treatment?
Rituximab is a medication which is designed to target rogue B-cells, a component of the immune system, in the body. It is used in the treatment of some types of leukemia and lymphoma, along with autoimmune conditions such as rheumatoid arthritis. This drug is sold under the trade names MabThera and Rituxan, and it is available by prescription only.
What is rituximab infusion for?
Rituxan (rituximab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. It is also used to treat other non-cancer conditions. Rituxan is an intravenous (IV) infusion given by a healthcare professional.